Observational Study
Copyright ©The Author(s) 2017.
World J Gastrointest Endosc. Apr 16, 2017; 9(4): 196-203
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.196
Table 1 Summary of patient demographics, adenoma morphology and investigations utilized n (%)
Non-ampullary (n = 18)Ampullary (n = 10)
Demographics
Median age, yr (range)69 (47-88)67 (48-80)
Male: female9:95:5
Morphology
Pedunculated3 (17)1 (10)
Sessile15 (83)9 (90)
Median size, mm (range)15 (9-24)20 (10-35)
Number ≥ 20 mm7 (39)6 (60)
Investigations
Biopsy7 (39)8 (80)
EUS3 (17)0
ERCP010 (100)
Table 2 Summary of treatment, biopsy and final pathology and recurrence
Non-ampullary (n = 18)Ampullary (n = 10)
Endoscopic treatment158
Stenting
Biliary02
Pancreatic05
Specimen removal
Piecemeal116
En bloc42
Complications01
Surgical resection21
No treatment11
Histology
1 no dysplasia7 low grade dysplasia
13 low grade dysplasia1 high grade dysplasia
3 high grade dysplasia1 adenocarcinoma
Concordance with biopsy4/77/8
Recurrence55
Table 3 Comparison of characteristics of recurrences (n = 10) vs no recurrence (n = 10)
Recurrence (n = 10)No recurrence (n = 10)
Non-ampullary/ ampullary5:57:3
Median size (mm)20 mm10 mm
Treatment
Endoscopic resection108
Surgical resection02
Specimen retrieval
Piecemeal86
En bloc24
Margin positivity9 (90%)6 (60%)
Salvage therapy
Endoscopic resection8
Surgical resection2